Exploratory Study of Peristomal and Non-Peristomal Skin Barrier Characteristics in People With a Stoma
Stoma Imprint
An Exploratory Study of Peristomal and Non-Peristomal Skin Barrier Characterisation in People Living With a Stoma.
1 other identifier
observational
108
1 country
1
Brief Summary
The purpose of this exploratory study is to obtain preliminary data on peristomal and non-peristomal skin barrier characterisation in people living with a stoma. The main questions it aims to answer are:
- Is there a difference/similarity in skin barrier characterisation of peristomal and non-peristomal skin in people living with a stoma?
- Is there a difference/similarity in peristomal skin barrier function of different stoma types (colostomy, ileostomy and urostomy)?
- Does a stoma type/function, influence skin barrier characterisation of peristomal skin? Participants will:
- Attend a 1-hour study appointment
- Undergo non-invasive skin procedures
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2026
CompletedFirst Posted
Study publicly available on registry
July 22, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
Study Completion
Last participant's last visit for all outcomes
May 1, 2028
July 22, 2026
July 1, 2026
1.7 years
July 14, 2026
July 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Assessment description of skin microbial composition of peristomal and non-peristomal skin
Each participant will provide four skin swab samples for microbiome profiling: two swabs from the peristomal (experimental) test site area and two swabs from the non-peristomal (control) test site area, on the opposite side of the abdomen. To Identify microbial species, present in peristomal and non-peristomal area using Metagenomic Shotgun Sequencing
Study appointment (1 hour)
Assessment of skin barrier chemical composition including water (mass-%), ceramides & fatty acids urea, lactate, protein, natural moisturising factors (NMF) and stratum corneum (SC) thickness of peristomal and non-peristomal skin
6 High Wavenumber profiles of water (mass%) and SC thickness (Microns) and 6 Fingerprint profiles of ceramides \& fatty acids urea, lactate, protein and natural moisturising factors (NMF) from peristomal skin (experimental) test site area and non-peristomal (control) skin test site area, using the Raman spectrometer
Study Appointment (1 hour)
Biophysical skin properties including Transepidermis water loss (TEWL), redness and skin colour, elasticity, sebum and pH of peristomal and non-peristomal skin
Measurement of Transepidermal water loss (TEWL) with Tewameter, skin colour (melanin) and skin redness (erythema) with Mexameter, elasticity and firmness with Cutometer, sebum level with Subumeter and pH with pH Meter from peristomal area (experimental) skin test and non-peristomal (control) skin test area
Study Appointment (1 hour)
Secondary Outcomes (3)
Compare microbiota analysis of each peristomal skin stoma type (Colostomy, Ileostomy and Urostomy)
Study Appointment (1 hour)
Compare skin barrier chemical composition including water (mass-%), ceramides & fatty acids urea, lactate, protein, natural moisturising factors (NMF) and stratum corneum (SC) thickness of each stoma type peristomal skin
Study Appointment (1 hour)
Compare biophysical skin properties including Transepidermis water loss (TEWL), redness and skin colour, elasticity, sebum and pH of stoma type (Colostomy, Ileostomy and Urostomy) peristomal skin
Study Appointment (1 hour)
Other Outcomes (1)
Correlation between peristomal skin barrier characterisation and stoma type/function and management
Study Appointment (1 hour)
Study Arms (1)
People Living with a Stoma
Colostomy, Ileostomy, Urostomy
Eligibility Criteria
The study population will be recruited from Birmingham UK and the surrounding areas (up to a distance of 150 miles)
You may qualify if:
- Adult 18 years or over
- Have a stoma (colostomy, ileostomy or urostomy)
- Have healthy peristomal skin
- Have the ability to provide informed consent
- Are independently mobile
- Can stop using any stoma paste, cream, sprays or lotions on peristomal skin 1 day (24hrs) prior to the study appointment
- Are independent with stoma care management
- Are able to attend study appointment in Birmingham, UK
You may not qualify if:
- Have a current skin condition, such as eczema, psoriasis, or infection around the skin test site areas
- Have bleeding or broken peristomal skin
- Are currently taking any of the following medications: steroids, nicotine patches, acne medication (e.g., Accutane), any medication know to affect the properties of the skin
- Use patches on your abdomen, such as HRT patches
- Are receiving or have had radiotherapy or chemotherapy in the last 2 months
- Are taking or have had antibiotic treatment in the last 4 weeks
- Are currently receiving any stoma care treatment under a stoma care nurse specialist
- Have tattoos in the skin test site areas
- Are pregnant
- Have excessive hair on your abdomen
- Have participated in another skin testing study within the last 8 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Salts Healthcarelead
Study Sites (1)
Salts Healthcare
Birmingham, B7 4AA, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Mireille Hamson
Salts Healthcare
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2026
First Posted
July 22, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
May 1, 2028
Last Updated
July 22, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share